戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              Lesch-Nyhan disease (LND) is an X-linked genetic disorde
2                                              Lesch-Nyhan disease (LND) is caused by congenital defici
3                                              Lesch-Nyhan disease (LND) is caused by deficiency of the
4                                              Lesch-Nyhan Disease (LND) is the result of mutations in
5                                              Lesch-Nyhan disease and its attenuated variants are caus
6                                              Lesch-Nyhan disease is a neurogenetic disorder caused by
7                                              Lesch-Nyhan disease is a rare, devastating, X-linked rec
8                                              Lesch-Nyhan disease is an X-linked recessive disorder th
9                                              Lesch-Nyhan syndrome encompasses a host of neurological
10 f 78 prior reports describing a total of 127 Lesch-Nyhan disease variants.
11  pathological conditions such as cholera and Lesch-Nyhan syndrome.
12 A deficiency states such as Parkinsonism and Lesch-Nyhan disease.
13 pectively model Parkinson's disease (PD) and Lesch-Nyhan syndrome (LNS).
14 alvage pathway, and mutations in HPRT1 cause Lesch-Nyhan disease.
15 at directly contacts the Mg(2+) ions, causes Lesch-Nyhan syndrome (HGPRT(Kinston), D193N).
16 nd of the spectrum are patients with classic Lesch-Nyhan disease and the full clinical phenotype.
17 ruary 1, 2009, issue of Genes & Development, Lesch and colleagues describe a new transcription factor
18  of non-dopaminergic neuronal development in Lesch-Nyhan syndrome.
19  from germ-line HPRT mutations identified in Lesch-Nyhan syndrome or hyperuricemia patients.
20 amine (DA) deficiency has been implicated in Lesch-Nyhan disease (LND), a genetic disorder that is ch
21 emical abnormalities in adulthood that mimic Lesch-Nyhan disease, schizophrenia, and other developmen
22 act on the use of female hiPSCs for modeling Lesch-Nyhan syndrome.
23 RT) cause the intractable neurodevelopmental Lesch-Nyhan disease (LND) associated with aberrant devel
24 ical manifestations of the largest cohort of Lesch-Nyhan disease variants evaluated to date, with 46
25 ibosyltransferase (HGPRTase) is the locus of Lesch-Nyhan syndrome, the activator of the prodrugs 6-me
26 s with 6-hydroxydopamine (6-OHDA; a model of Lesch-Nyhan syndrome (LNS)) or vehicle (unlesioned rats)
27 me (DS)/trisomy 21, and the carrier state of Lesch-Nyhan syndrome.
28 e (HPRT) deficiency in humans results in the Lesch-Nyhan syndrome which is characterized, among other
29  a disorder in the HPRT gene (leading to the Lesch-Nyhan syndrome) is unique to human, chimpanzee, an
30 behavioral abnormalities associated with the Lesch-Nyhan syndrome as previously suggested.
31  the behavioral symptoms associated with the Lesch-Nyhan syndrome.
32 rited mutations in the human HPRT leading to Lesch-Nyhan syndrome (D193N) or gout (S103R or S109L), a
33  are unlikely to contribute substantially to Lesch-Nyhan syndrome burden.
34              These factors are not unique to Lesch-Nyhan disease, and are relevant to most other gene
35 l to HPRT1, the housekeeping gene underlying Lesch-Nyhan syndrome, an X-linked recessive disorder.
36 ic regions of the brains of 12 patients with Lesch-Nyhan disease (age, 10 to 20 years) and 15 healthy
37                                Patients with Lesch-Nyhan disease have abnormally few dopaminergic ner
38  tegmentum; 57 percent) in the patients with Lesch-Nyhan disease than in the controls.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。